SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-16-097333
Filing Date
2016-02-16
Accepted
2016-02-16 16:10:56
Documents
1
Group Members
MONTREUX EQUITY MANAGEMENT IV, LLCMONTREUX EQUITY MANAGEMENT V, LLCMONTREUX EQUITY PARTNERS V, L.P.MONTREUX IV ASSOCIATES, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a16-4673_1sc13ga.htm SC 13G/A 157734
  Complete submission text file 0001104659-16-097333.txt   159660
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Subject) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87592 | Film No.: 161428217
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111
Business Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111 650-234-1200
MONTREUX EQUITY PARTNERS IV LP (Filed by) CIK: 0001423641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA
Type: SC 13G/A